urea has been researched along with Disease, Pulmonary in 37 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The response to continuous intravenous infusion of landiolol was evaluated in 25 patients who developed post-operative atrial fibrillation or atrial flutter after major pulmonary resection." | 7.78 | Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection. ( Ibe, T; Kamiyoshihara, M; Kawashima, O; Nagashima, T; Nakano, T; Shimizu, K; Takeyoshi, I, 2012) |
| "The response to continuous intravenous infusion of landiolol was evaluated in 25 patients who developed post-operative atrial fibrillation or atrial flutter after major pulmonary resection." | 3.78 | Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection. ( Ibe, T; Kamiyoshihara, M; Kawashima, O; Nagashima, T; Nakano, T; Shimizu, K; Takeyoshi, I, 2012) |
| " The following short-term glucocorticoid-induced effects were investigated in 25 HC-treated and 25 control patients in centre A, and in 23 DEX-treated and 23 control patients in centre B: oxygen dependency (inspiratory oxygen fraction), arterial pressure, blood glucose and urea concentrations, weight gain and head circumference before, during and after therapy (in treated infants), or at an interval comparable to treated infants (in control infants)." | 3.72 | Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone? ( Bakker, JM; Heijnen, CJ; Kamphuis, PJ; van Bel, F; van der Heide-Jalving, M; van der Laan, MJ; Veen, S; Wiegant, VM, 2003) |
| "In asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis, increased arginase activity in the airways may contribute to obstruction and hyperresponsiveness of the airways by inducing a reduction in the production of bronchodilatory nitric oxide (NO) that results from its competition with constitutive (cNOS) and inducible (iNOS) NO synthases for their common substrate." | 2.44 | Arginase and pulmonary diseases. ( Maarsingh, H; Meurs, H; Pera, T, 2008) |
| "The role of these factors in the pulmonary disease associated with cystic fibrosis is not clear." | 1.28 | Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis. ( Gessner, AR; Mortensen, JE, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (54.05) | 18.7374 |
| 1990's | 8 (21.62) | 18.2507 |
| 2000's | 7 (18.92) | 29.6817 |
| 2010's | 2 (5.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fallacara, A | 1 |
| Busato, L | 1 |
| Pozzoli, M | 1 |
| Ghadiri, M | 1 |
| Ong, HX | 1 |
| Young, PM | 1 |
| Manfredini, S | 1 |
| Traini, D | 1 |
| Nakano, T | 1 |
| Shimizu, K | 1 |
| Kawashima, O | 1 |
| Kamiyoshihara, M | 1 |
| Nagashima, T | 1 |
| Ibe, T | 1 |
| Takeyoshi, I | 1 |
| Joseph, M | 1 |
| Hageman, JR | 1 |
| van der Heide-Jalving, M | 1 |
| Kamphuis, PJ | 1 |
| van der Laan, MJ | 1 |
| Bakker, JM | 1 |
| Wiegant, VM | 1 |
| Heijnen, CJ | 1 |
| Veen, S | 1 |
| van Bel, F | 1 |
| Rich, PB | 1 |
| Douillet, CD | 1 |
| Hurd, H | 1 |
| Boucher, RC | 1 |
| ELLIOT, A | 1 |
| BRADLEY, RD | 1 |
| SPENCER, GT | 1 |
| SEMPLE, SJ | 1 |
| JICK, H | 1 |
| KAMM, DE | 1 |
| SNYDER, JG | 1 |
| MORRISON, RS | 1 |
| CHALMERS, TC | 1 |
| DEBOER, J | 1 |
| TODD, RS | 1 |
| LAINE, JB | 1 |
| SINGH, LM | 1 |
| VEGA, RE | 1 |
| HEIDER, C | 1 |
| HOWARD, JM | 1 |
| BARBOLINI, G | 1 |
| BISETTI, A | 1 |
| LOMBARDI, R | 1 |
| STERNIERI, E | 1 |
| Musch, W | 1 |
| Hedeshi, A | 1 |
| Decaux, G | 1 |
| Gawlowski, Z | 1 |
| Aladangady, N | 1 |
| Coen, PG | 1 |
| Maarsingh, H | 1 |
| Pera, T | 1 |
| Meurs, H | 1 |
| Plöchl, E | 1 |
| Bachmann, C | 1 |
| Von Wichert, P | 1 |
| Joseph, K | 1 |
| Müller, B | 1 |
| Franck, WM | 1 |
| Manary, MJ | 1 |
| Brewster, DR | 1 |
| Broadhead, RL | 1 |
| Crowley, JR | 1 |
| Fjeld, CR | 1 |
| Yarasheski, KE | 1 |
| Dargaville, PA | 1 |
| South, M | 1 |
| Vervaart, P | 1 |
| McDougall, PN | 1 |
| Bos, AF | 1 |
| van Asselt, WA | 1 |
| Okken, A | 1 |
| Blackburn, GL | 1 |
| Maini, BS | 1 |
| Pierce, EC | 1 |
| Lyons, DJ | 1 |
| Donald, S | 1 |
| Mitchell, DN | 1 |
| Asherson, GL | 1 |
| van de Graaf, EA | 1 |
| Jansen, HM | 1 |
| Weber, JA | 1 |
| Koolen, MG | 1 |
| Out, TA | 1 |
| Jones, KP | 2 |
| Reynolds, SP | 2 |
| Capper, SJ | 1 |
| Kalinka, S | 1 |
| Edwards, JH | 2 |
| Davies, BH | 2 |
| Gessner, AR | 1 |
| Mortensen, JE | 1 |
| Nelson, J | 1 |
| Ormrod, DJ | 1 |
| Miller, TE | 1 |
| Grosse, G | 1 |
| Höfer, W | 1 |
| Gruska, H | 1 |
| Beyer, KH | 1 |
| Kubicki, S | 1 |
| Schirop, T | 1 |
| Grabensee, B | 1 |
| Hofmann, K | 1 |
| Jax, W | 1 |
| Königshausen, T | 1 |
| Schnurr, E | 1 |
| Schröder, E | 1 |
| Pearson, HA | 1 |
| Diamond, LK | 1 |
| Burnett, W | 1 |
| McCaffrey, J | 1 |
| Bennett, R | 1 |
| Bluestone, R | 1 |
| Holt, PJ | 1 |
| Bywaters, EG | 1 |
| Cat, I | 1 |
| Marçallo, FA | 1 |
| Marinoni, LP | 1 |
| Giraldi, DJ | 1 |
| Costa, O | 1 |
| Braga, H | 1 |
| Malyshev, IuI | 1 |
| Dement'eva, AM | 1 |
| Karpova, EP | 1 |
| Kaninina, TA | 1 |
| Kondranin, GV | 1 |
| Polianskii, GN | 1 |
| Everitt, AV | 1 |
| Hirsch, SR | 1 |
| Zastrow, JE | 1 |
| Kory, RC | 1 |
| Highman, B | 1 |
| Altland, PD | 1 |
| Garbus, J | 1 |
| Blainey, JD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Early Sodium Intake in Preterm Newborns; Randomized Clinical Trial[NCT04035564] | Phase 4 | 52 participants (Actual) | Interventional | 2018-03-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The difference between initial weight and 72hrs weight, expressed in percentage of birth weight. (NCT04035564)
Timeframe: Initial weight (baseline) vs 72 hours
| Intervention | % of birth weight (Mean) |
|---|---|
| Sodium < 1mEq/kg/Day | -9.206 |
| Sodium 5mEq/kg/Day | -6.345 |
The difference between current serum sodium and initial serum sodium (NCT04035564)
Timeframe: Initial serum sodium (baseline) vs 72 hours
| Intervention | mEq/L (Mean) |
|---|---|
| Sodium < 1mEq/kg/Day | 1.921 |
| Sodium 5mEq/kg/Day | 5.71 |
serum sodium >150mEq/L (NCT04035564)
Timeframe: 72 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Sodium < 1mEq/kg/Day | 1 |
| Sodium 5mEq/kg/Day | 1 |
serum sodium <130mEq/L (NCT04035564)
Timeframe: 72 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Sodium < 1mEq/kg/Day | 6 |
| Sodium 5mEq/kg/Day | 1 |
Death during hospitalization. (NCT04035564)
Timeframe: Patients will be followed during hospitalization, an expected average of 3 months of age
| Intervention | Participants (Count of Participants) |
|---|---|
| Sodium < 1mEq/kg/Day | 5 |
| Sodium 5mEq/kg/Day | 2 |
Bleeding into the brain´s ventricular system (intracranial ultrasound). (NCT04035564)
Timeframe: Patients will be followed during hospitalization, an expected average of 3 months of age
| Intervention | Participants (Count of Participants) |
|---|---|
| Sodium < 1mEq/kg/Day | 6 |
| Sodium 5mEq/kg/Day | 4 |
Positive blood culture and/or 5 days of continuous antimicrobial therapy (NCT04035564)
Timeframe: Patients will be followed during hospitalization, an expected average of 3 months of age
| Intervention | Participants (Count of Participants) |
|---|---|
| Sodium < 1mEq/kg/Day | 8 |
| Sodium 5mEq/kg/Day | 5 |
"Number of patients with Bell stage II or greater necrotizing enterocolitis~Bell's Staging:~Stage II A:~Gastrointestinal signs: Increasing gastric aspirates, mild abdominal distention, fecal occult blood, absent bowel sounds.~Systemic signs: Temperature instability, apnea, bradycardia, lethargy. Radiological findings: Intestinal dilatation, ileus, pneumatosis intestinalis.~Stage II B:~Gastrointestinal signs: As stage IIA plus abdominal tenderness. Systemic signs: As stage IIA plus metabolic acidosis and thrombocytopenia. Radiological findings: As stage IIA plus portal vein gas and ascites.~Stage III A:~Gastrointestinal signs: As stage IIB plus marked abdominal tenderness and generalised peritonitis.~Systemic signs: As stage IIB plus hypotension and severe apnea. Radiological findings: As stage IIB~Stage III B:~Gastrointestinal signs: As stage IIIA As stage IIIA As stage IIIA plus pneumoperitoneum" (NCT04035564)
Timeframe: Patients will be followed during hospitalization, an expected average of 3 months of age
| Intervention | Participants (Count of Participants) |
|---|---|
| Sodium < 1mEq/kg/Day | 2 |
| Sodium 5mEq/kg/Day | 2 |
The difference between current weight and initial weight (NCT04035564)
Timeframe: Initial weight (baseline) vs 72 hours
| Intervention | Grams (Mean) |
|---|---|
| Sodium < 1mEq/kg/Day | -135.43 |
| Sodium 5mEq/kg/Day | -96.05 |
3 reviews available for urea and Disease, Pulmonary
| Article | Year |
|---|---|
Arginase and pulmonary diseases.
Topics: Animals; Arginase; Arginine; Asthma; Cystic Fibrosis; Disease Models, Animal; Humans; Hypertension, | 2008 |
Nutrition in the critically ill patient.
Topics: Amino Acids; Boston; Critical Care; Diabetes Mellitus; Dietary Carbohydrates; Dietary Fats; Dietary | 1977 |
The critically ill child: sickle cell disease crises and their management.
Topics: Abdomen; Acidosis; Anemia, Sickle Cell; Bilirubin; Blood Cell Count; Blood Transfusion; Child; Chole | 1971 |
34 other studies available for urea and Disease, Pulmonary
| Article | Year |
|---|---|
Co-Spray-Dried Urea Cross-Linked Hyaluronic Acid and Sodium Ascorbyl Phosphate as Novel Inhalable Dry Powder Formulation.
Topics: Administration, Inhalation; Aerosols; Anti-Inflammatory Agents; Ascorbic Acid; Cell Line, Tumor; Che | 2019 |
Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Atrial Fibrillation; Atrial Flutter | 2012 |
Neonatal transport: a 3-day-old neonate with hypothermia, respiratory distress, lethargy and poor feeding.
Topics: Ammonia; Blood Gas Analysis; Combined Modality Therapy; Critical Care; Diagnosis, Differential; Hemo | 2002 |
Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone?
Topics: Anti-Inflammatory Agents; Blood Glucose; Body Weight; Child; Child, Preschool; Chronic Disease; Dexa | 2003 |
Effect of ventilatory rate on airway cytokine levels and lung injury.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cytokines; L-Lactate Dehydrogenase; Lung Diseases; Male; Mode | 2003 |
Hyperchloremia, azotemia and pulmonary edema of cerebral origin.
Topics: Azotemia; Blood; Chlorides; Edema; Humans; Lung Diseases; Multiple Sclerosis; Nitrogen; Pulmonary Ed | 1955 |
TRACHEOSTOMY AND ARTIFICIAL VENTILATION IN THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC LUNG DISEASE. A STUDY IN TWENTY-NINE PATIENTS.
Topics: Asthma; Blood Chemical Analysis; Blood Gas Analysis; Bronchitis; Bronchopneumonia; Geriatrics; Human | 1964 |
ON THE CONCENTRATING DEFECT IN CIRRHOSIS OF THE LIVER.
Topics: Alcoholism; Arthritis; Arthritis, Rheumatoid; Coronary Disease; Dehydration; Dermatitis; Diabetes Me | 1964 |
EVALUATION OF LUNG LAVAGE AS A THERAPEUTIC MEASURE IN UREMIA.
Topics: Animals; Bronchoalveolar Lavage; Creatine; Creatinine; Dialysis; Dogs; Electrons; Lung; Lung Disease | 1963 |
EFFECTS OF ALDOSTERONE ON PROLONGATION OF RENAL HOMOTRANSPLANTS IN DOGS.
Topics: Acute Kidney Injury; Aldosterone; Blood Urea Nitrogen; Dogs; Kidney; Kidney Function Tests; Kidney T | 1964 |
[EXPERIMENTAL UREMIC PNEUMOPATHY IN THE RABBIT. MORPHOLOGIC AND DYNAMIC STUDY WITH C 14-UREA].
Topics: Animals; Carbon Isotopes; Carbon Radioisotopes; Lagomorpha; Lung Diseases; Rabbits; Research; Urea; | 1964 |
Low sodium excretion in SIADH patients with low diuresis.
Topics: Aged; Alcohol Withdrawal Seizures; Alcoholism; Creatinine; Diagnosis, Differential; Diuresis; Duoden | 2004 |
Hypernatraemia in preterm infants born at less than 27 weeks gestation.
Topics: Birth Weight; Creatine; Ductus Arteriosus, Patent; Enterocolitis, Necrotizing; Female; Fluid Therapy | 2006 |
[Pulmonary hemorrhages in newborn infants with inborn errors of the 1st 2 phases of the urea cycle].
Topics: Amino Acid Metabolism, Inborn Errors; Ammonia; Carbamoyl-Phosphate Synthase (Ammonia); Hemorrhage; H | 1983 |
Bronchoalveolar lavage. Quantitation of intraalveolar fluid?
Topics: Animals; Body Fluids; Bronchitis; Bronchoalveolar Lavage Fluid; Chronic Disease; Edetic Acid; Humans | 1993 |
Protein metabolism in children with edematous malnutrition and acute lower respiratory infection.
Topics: Acute Disease; Acute-Phase Proteins; Albumins; Carbon Isotopes; Child, Preschool; Female; Gas Chroma | 1997 |
Validity of markers of dilution in small volume lung lavage.
Topics: Albumins; Analysis of Variance; Biomarkers; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Hu | 1999 |
Dexamethasone treatment and fluid balance in preterm infants at risk for chronic lung disease.
Topics: Anti-Inflammatory Agents; Blood Glucose; Blood Pressure; Chronic Disease; Creatinine; Dexamethasone; | 2000 |
Chemical inactivation of the Kveim reagent.
Topics: Chemical Fractionation; Humans; Indicators and Reagents; Kveim Test; Lung Diseases; Mercaptoethanol; | 1992 |
Influx of urea during bronchoalveolar lavage depends on the permeability of the respiratory membrane.
Topics: Albumins; Alpha-Globulins; Blood-Air Barrier; Bronchi; Bronchoalveolar Lavage Fluid; Ceruloplasmin; | 1991 |
Measurement of interleukin-6 in bronchoalveolar lavage fluid by radioimmunoassay: differences between patients with interstitial lung disease and control subjects.
Topics: Albumins; Bird Fancier's Lung; Bronchoalveolar Lavage Fluid; Female; Humans; Immunoglobulin G; Inter | 1991 |
Down regulation in hypersensitivity pneumonitis.
Topics: Adult; Animals; Bird Fancier's Lung; Bronchoalveolar Lavage Fluid; Columbidae; Epithelium; Humans; L | 1990 |
Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis.
Topics: Amino Acids; Catalase; Cystic Fibrosis; Cytotoxins; Endopeptidases; Glycoside Hydrolases; Hemolysis; | 1990 |
Host immune status in uraemia. VI. Leucocytic response to bacterial infection in chronic renal failure.
Topics: Animals; Escherichia coli Infections; Female; Kidney Failure, Chronic; Leukocytes; Lung Diseases; Ma | 1985 |
[The clinical course of severe carbromal poisoning (author's transl)].
Topics: Acute Kidney Injury; Adult; Electroencephalography; Female; Heparin; Humans; Intubation, Intratrache | 1974 |
[Clinical features and treatment of carbromal poisoning].
Topics: Adult; Arrhythmias, Cardiac; Diuresis; Female; Follow-Up Studies; Humans; Lung Diseases; Male; Middl | 1972 |
Surgical procedures in the elderly.
Topics: Aged; Anemia; Blood Volume; Female; Geriatrics; Heart Diseases; Humans; Hypertension; Lung Diseases; | 1972 |
Survival in scleroderma.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Electrocardiography; Female; Humans; Lung Diseases; Mal | 1971 |
Syndrome of cellular agony--biochemical characterization.
Topics: Autopsy; Child; Death; Gastroenteritis; Humans; Hyperglycemia; Hyperkalemia; Hyponatremia; Kwashiork | 1969 |
[Postoperative changes in the water-salt balance in patients undergoing surgery in connection with diseases of organs of the chest cavity].
Topics: Cardiac Surgical Procedures; Chlorides; Creatinine; Esophageal Neoplasms; Hematuria; Humans; Inflamm | 1968 |
The effect of chronic lung disease and the process of dying on the ageing of collagen fibres in the male rat.
Topics: Aging; Animals; Appetite; Bronchiectasis; Chronic Disease; Collagen; Death; Lung Abscess; Lung Disea | 1969 |
Sputum liquefying agents: a comparative in vitro evaluation.
Topics: Acetylcysteine; Bicarbonates; Humans; Lung Diseases; Mercaptoethanol; Methods; Potassium Iodide; Sod | 1969 |
Pathological and serum-enzyme changes after epinephrine in oil and adrenergic blocking agent.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Blood; Blood Urea | 1965 |
Acute nephritis and pulmonary disease.
Topics: Adult; Biopsy; Blood; Blood Proteins; Bronchiectasis; Bronchitis; Complement Fixation Tests; Creatin | 1966 |